ATE322907T1 - Plasma-albumin fraktion mit vermindertem prekallikrein - Google Patents

Plasma-albumin fraktion mit vermindertem prekallikrein

Info

Publication number
ATE322907T1
ATE322907T1 AT03767649T AT03767649T ATE322907T1 AT E322907 T1 ATE322907 T1 AT E322907T1 AT 03767649 T AT03767649 T AT 03767649T AT 03767649 T AT03767649 T AT 03767649T AT E322907 T1 ATE322907 T1 AT E322907T1
Authority
AT
Austria
Prior art keywords
fraction
reduced
precallikrein
plasma
albumine
Prior art date
Application number
AT03767649T
Other languages
English (en)
Inventor
Werner Gehringer
Katharina Pock
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32337993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE322907(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of ATE322907T1 publication Critical patent/ATE322907T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03767649T 2002-11-25 2003-11-25 Plasma-albumin fraktion mit vermindertem prekallikrein ATE322907T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02026165 2002-11-25

Publications (1)

Publication Number Publication Date
ATE322907T1 true ATE322907T1 (de) 2006-04-15

Family

ID=32337993

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03767649T ATE322907T1 (de) 2002-11-25 2003-11-25 Plasma-albumin fraktion mit vermindertem prekallikrein

Country Status (23)

Country Link
US (1) US7700732B2 (de)
EP (1) EP1565207B1 (de)
JP (1) JP4532282B2 (de)
KR (1) KR101077651B1 (de)
CN (1) CN100364609C (de)
AT (1) ATE322907T1 (de)
AU (1) AU2003292109B2 (de)
BR (1) BR0316563A (de)
CA (1) CA2506848C (de)
DE (1) DE60304603T2 (de)
DK (1) DK1565207T3 (de)
ES (1) ES2261977T3 (de)
IL (1) IL168506A (de)
MX (1) MXPA05005328A (de)
NO (1) NO330216B1 (de)
PL (1) PL375539A1 (de)
PT (1) PT1565207E (de)
RS (1) RS20050401A (de)
RU (1) RU2321421C2 (de)
SI (1) SI1565207T1 (de)
UA (1) UA77596C2 (de)
WO (1) WO2004047859A2 (de)
ZA (1) ZA200504202B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2221817B1 (es) 2004-07-26 2005-10-01 Probitas Pharma, S.A. "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas".
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
SE1050124A1 (sv) 2010-02-08 2011-08-09 Linkoping Biocontrols Ab Stabil lösning
GB201317458D0 (en) * 2013-10-02 2013-11-13 Spd Swiss Prec Diagnostics Gmbh Improved pregnancy test device and method
CN107216383A (zh) * 2017-07-13 2017-09-29 同路生物制药有限公司 一种人血白蛋白的制备方法及该人血白蛋白

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2190436B1 (de) * 1972-07-05 1975-06-20 Merieux Inst
US4378346A (en) 1979-08-15 1983-03-29 Tankersley Donald L Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
US4251510A (en) 1979-08-15 1981-02-17 Cutter Laboratories, Inc. Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
EP0035204B2 (de) * 1980-03-05 1991-05-22 Miles Inc. Pasteurisierte therapeutisch aktive Proteinzusammensetzungen
US4391801A (en) 1981-10-29 1983-07-05 Cutter Laboratories, Inc. Plasma protein fraction substantially free of acetate ions
AT376367B (de) 1983-03-16 1984-11-12 Immuno Ag Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten
SU1212416A1 (ru) * 1984-04-03 1986-02-23 Научно-Исследовательский Институт Гематологии И Переливания Крови Им.Проф.Р.О.Еоляна Способ выделени альбумина из плазмы крови
AT391810B (de) 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
RU2007423C1 (ru) * 1991-06-04 1994-02-15 Институт биофизики клетки РАН Способ очистки сывороточного альбумина
US5919907A (en) * 1997-12-22 1999-07-06 Shanbrom Technologies Llc Preparation and utilization of a novel sterile albumin
US6693173B2 (en) 2000-12-26 2004-02-17 Alpha Therapeutic Corporation Method to remove citrate and aluminum from proteins

Also Published As

Publication number Publication date
KR101077651B1 (ko) 2011-10-27
RU2321421C2 (ru) 2008-04-10
BR0316563A (pt) 2005-10-04
ES2261977T3 (es) 2006-11-16
PT1565207E (pt) 2006-07-31
CN100364609C (zh) 2008-01-30
AU2003292109A1 (en) 2004-06-18
DE60304603D1 (de) 2006-05-24
CA2506848C (en) 2012-09-11
SI1565207T1 (sl) 2006-08-31
ZA200504202B (en) 2006-02-22
NO20052550D0 (no) 2005-05-26
IL168506A (en) 2010-11-30
NO20052550L (no) 2005-08-12
WO2004047859A3 (en) 2004-08-05
RU2005119987A (ru) 2006-01-20
UA77596C2 (en) 2006-12-15
EP1565207A2 (de) 2005-08-24
DE60304603T2 (de) 2007-02-15
CN1717249A (zh) 2006-01-04
EP1565207B1 (de) 2006-04-12
AU2003292109B2 (en) 2009-02-05
JP2006518705A (ja) 2006-08-17
KR20050085043A (ko) 2005-08-29
CA2506848A1 (en) 2004-06-10
US20060100419A1 (en) 2006-05-11
RS20050401A (sr) 2007-06-04
JP4532282B2 (ja) 2010-08-25
US7700732B2 (en) 2010-04-20
NO330216B1 (no) 2011-03-07
PL375539A1 (en) 2005-11-28
DK1565207T3 (da) 2006-08-14
MXPA05005328A (es) 2005-08-16
WO2004047859A2 (en) 2004-06-10

Similar Documents

Publication Publication Date Title
DE60322513D1 (de) Stabilisierte TNFR-Fc Formulierung mit Arginin
DE60329309D1 (de) Vorrichtung zur verpackung von länglichen chirurgischen vorrichtungen
DK239586D0 (da) Fremgangsmaade til transport af levende fisk
DE60234444D1 (de) Verfahren zur herstellung von l-aminosäuren mit stämmen der familie enterobacteriaceae
ATE382358T1 (de) Verfahren und zusammensetzungen zum sauerstofftransport mit hoher sauerstoffaffinität
ATE426400T1 (de) Wirkstoffhaltige filmfírmige zubereitungen mit verbesserter chemischer stabilitat, und verfahren zu deren herstellung
ATE322907T1 (de) Plasma-albumin fraktion mit vermindertem prekallikrein
NO20051654L (no) Forlenget frigjoring av farmasoytisk preparat
CA2531419C (fr) Procede de stabilisation d'un cryoprecipite de proteines plasmatiques destine a etre soumis a un traitement thermique d'inactivation virale
ATE362322T1 (de) Kaffeezusammensetzungen mit stabilen aromaeigenschaften und verfahren zu deren herstellung
IS7578A (is) Efnablöndur sem innihalda vítamín, málmsalt og insúlín eða vaxtarhormón til að nota í meðferð
DE50205186D1 (de) Verfahren und Vorrichtung zur Erhitzung von in Trays eingesiegelten Fertiggerichten mit Mikrowellen
DK1329460T3 (da) Fremgangsmåde til monomerisering af polymerer af humant serum albumin
WO2005017237A3 (en) Apparatus and method for the selective assembly of protein
EP1544318A4 (de) ATMOSPHûRENWûRMEBEHANDLUNGSCOKATALYSATOR, VERFAHREN ZU SEINER ANWENDUNG, WûRMEBEHANDLUNGSVERFAHREN UND WûRMEBEHANDLUNGSATMOSPHûRE DER VERWENDUNG DES COKATALYSATORS
WO2003059943A3 (en) Conformation-specific, protein kinase binding peptides and related methods and products
ATE404545T1 (de) Acylaminothiazolderivate, verfahren zu deren herstellung und deren verwendung als inhibitoren der produktion von beta-amyloidpeptid
PL374400A1 (en) Pasta compostions
DE69809935D1 (de) VERFAHREN UND EINRICHTUNG ZUr KONSERVIERUnG VON NAHRUNGSMITTELN
MX9306614A (es) Composicion de metodos para la formacion de un insecticida.
ITBO20020484A1 (it) Impianto e metodo per la realizzazione di contenitori , in particolare per la conservazione di sostanze alimentari
UA67630A (en) Method for correcting stress component in experimental model of acute adnexitis
EP1618125A4 (de) Vitamin-c-derivate mit peptid, verfahren zu deren herstellung und zusammensetzung, die diese enthält
ATE386495T1 (de) Behältnis mit niedrigem sauerstoffgehalt, das ff- mas enthält
ATE321453T1 (de) Verfahren und verwendung von indol-derivaten zur verringerung des aufplatzens von obst- oder gemüsefrüchten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1565207

Country of ref document: EP